Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1954 1
1955 1
1956 1
1959 1
1961 2
1962 4
1963 4
1964 4
1966 1
1967 6
1968 1
1969 3
1970 4
1971 4
1972 4
1973 10
1974 4
1975 7
1976 12
1977 9
1978 8
1979 16
1980 20
1981 19
1982 20
1983 14
1984 18
1985 30
1986 28
1987 39
1988 28
1989 37
1990 35
1991 40
1992 45
1993 67
1994 78
1995 80
1996 105
1997 118
1998 108
1999 123
2000 143
2001 150
2002 193
2003 240
2004 290
2005 336
2006 379
2007 479
2008 560
2009 634
2010 771
2011 952
2012 1016
2013 1260
2014 1303
2015 1372
2016 1504
2017 1707
2018 1915
2019 2160
2020 2566
2021 2783
2022 3310
2023 946
Text availability
Article attribute
Article type
Publication date

Search Results

25,170 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.
Gao P, Wang T, Wang D, Liebeskind DS, Shi H, Li T, Zhao Z, Cai Y, Wu W, He W, Yu J, Zheng B, Wang H, Wu Y, Dmytriw AA, Krings T, Derdeyn CP, Jiao L; CASSISS Trial Investigators. Gao P, et al. Among authors: wu w. JAMA. 2022 Aug 9;328(6):534-542. doi: 10.1001/jama.2022.12000. JAMA. 2022. PMID: 35943472 Free PMC article. Clinical Trial.
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T.
Liu Q, Li J, Zheng H, Yang S, Hua Y, Huang N, Kleeff J, Liao Q, Wu W. Liu Q, et al. Among authors: wu w. Mol Cancer. 2023 Feb 7;22(1):28. doi: 10.1186/s12943-023-01735-9. Mol Cancer. 2023. PMID: 36750830 Free PMC article. Review.
Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial.
Ke L, Lin J, Doig GS, van Zanten ARH, Wang Y, Xing J, Zhang Z, Chen T, Zhou L, Jiang D, Shi Q, Lin J, Liu J, Cheng A, Liang Y, Gao P, Sun J, Liu W, Yang Z, Zhang R, Xing W, Zhang A, Zhou Z, Zhou T, Liu Y, Tong F, Wang Q, Pan A, Huang X, Fan C, Lu W, Shi D, Wang L, Li W, Gu L, Xie Y, Sun R, Guo F, Han L, Zhou L, Zheng X, Shan F, Liu J, Ai Y, Qu Y, Li L, Li H, Pan Z, Xu D, Zou Z, Gao Y, Yang C, Kou Q, Zhang X, Wu J, Qian C, Zhang W, Zhang M, Zong Y, Qin B, Zhang F, Zhai Z, Sun Y, Chang P, Yu B, Yu M, Yuan S, Deng Y, Zhao L, Zang B, Li Y, Zhou F, Chen X, Shao M, Wu W, Wu M, Zhang Z, Li Y, Guo Q, Wang Z, Gong Y, Song Y, Qian K, Feng Y, Fu B, Liu X, Li Z, Gong C, Sun C, Yu J, Tang Z, Huang L, Ma B, He Z, Zhou Q, Yu R, Tong Z, Li W; Chinese Critcal Care Nutrition Trials Group (CCCNTG). Ke L, et al. Among authors: wu w. Crit Care. 2022 Feb 16;26(1):46. doi: 10.1186/s13054-022-03921-5. Crit Care. 2022. PMID: 35172856 Free PMC article. Clinical Trial.
Systemic Cytokines in Retinopathy of Prematurity.
Wu PY, Fu YK, Lien RI, Chiang MC, Lee CC, Chen HC, Hsueh YJ, Chen KJ, Wang NK, Liu L, Chen YP, Hwang YS, Lai CC, Wu WC. Wu PY, et al. Among authors: wu wc. J Pers Med. 2023 Feb 5;13(2):291. doi: 10.3390/jpm13020291. J Pers Med. 2023. PMID: 36836525 Free PMC article. Review.
Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies.
Gao Q, Lin YP, Li BS, Wang GQ, Dong LQ, Shen BY, Lou WH, Wu WC, Ge D, Zhu QL, Xu Y, Xu JM, Chang WJ, Lan P, Zhou PH, He MJ, Qiao GB, Chuai SK, Zang RY, Shi TY, Tan LJ, Yin J, Zeng Q, Su XF, Wang ZD, Zhao XQ, Nian WQ, Zhang S, Zhou J, Cai SL, Zhang ZH, Fan J. Gao Q, et al. Among authors: wu wc. Ann Oncol. 2023 Feb 25:S0923-7534(23)00087-X. doi: 10.1016/j.annonc.2023.02.010. Online ahead of print. Ann Oncol. 2023. PMID: 36849097
Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
Zhang Y, Ji T, Ma S, Wu W. Zhang Y, et al. Among authors: wu w. Int Immunopharmacol. 2023 Feb 21;117:109865. doi: 10.1016/j.intimp.2023.109865. Online ahead of print. Int Immunopharmacol. 2023. PMID: 36822094 No abstract available.
Retraction notice to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region" [Int. Immunopharmacol. 82 (2020) 106220].
Zhang Y, Ji T, Ma S, Wu W. Zhang Y, et al. Among authors: wu w. Int Immunopharmacol. 2023 Feb 21;117:109869. doi: 10.1016/j.intimp.2023.109869. Online ahead of print. Int Immunopharmacol. 2023. PMID: 36822092 No abstract available.
25,170 results
You have reached the last available page of results. Please see the User Guide for more information.